Inhibikase Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 05/14/2025 | 10.95 M | $23.98 M | 0.00% | 12.23% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 6.33 M | $13.85 M | 0.00% | 7.06% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 5.93 M | $12.98 M | 0.00% | 6.62% |
| COMMODORE CAPITAL LP | 05/15/2025 | 5.34 M | $11.70 M | -9.80% | 5.97% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 5.12 M | $11.22 M | 0.37% | 5.72% |
| VANGUARD GROUP INC | 05/09/2025 | 2.85 M | $6.24 M | 0.35% | 3.18% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 2.19 M | $4.80 M | 0.00% | 2.45% |
| BLACKSTONE INC. | 05/15/2025 | 2.07 M | $4.53 M | 0.00% | 2.31% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 914.97 K | $2.00 M | -19.20% | 1.02% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 913.50 K | $2.00 M | 542.37% | 1.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 504.63 K | $1.11 M | 100.00% | 0.56% |
| BLACKROCK, INC. | 05/02/2025 | 423.98 K | $928.51 K | 26.39% | 0.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 324.76 K | $711.29 K | 0.58% | 0.36% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 166.03 K | $363.60 K | 277.74% | 0.19% |
| BLAIR WILLIAM & CO/IL | 05/09/2025 | 155.95 K | $341.54 K | 15.56% | 0.17% |
| MARSHALL WACE, LLP | 05/15/2025 | 155.27 K | $340.04 K | 100.00% | 0.17% |
| JANE STREET GROUP, LLC | 05/19/2025 | 116.25 K | $254.59 K | 100.00% | 0.13% |
| BARCLAYS PLC | 05/15/2025 | 84.00 K | $184.00 K | 0.00% | 0.09% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 81.16 K | $177.74 K | 100.00% | 0.09% |
| HRT FINANCIAL LP | 05/15/2025 | 65.91 K | $144.00 K | 41.99% | 0.07% |
| NORTHERN TRUST CORP | 05/13/2025 | 64.01 K | $140.18 K | 0.00% | 0.07% |
| OMERS ADMINISTRATION CORP | 05/14/2025 | 56.00 K | $122.64 K | 2.56% | 0.06% |
| 05/15/2025 | 54.85 K | $120.11 K | 100.00% | 0.06% | |
| UBS GROUP AG | 05/13/2025 | 45.27 K | $99.13 K | 64.45% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 45.03 K | $98.61 K | 898.58% | 0.05% |
| STATE STREET CORP | 05/15/2025 | 41.88 K | $91.73 K | 0.00% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 35.63 K | $78.02 K | 100.00% | 0.04% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2025 | 32.54 K | $71.00 K | 100.00% | 0.04% |
| LMR PARTNERS LLP | 05/15/2025 | 31.09 K | $68.09 K | 100.00% | 0.03% |
| DIAMETRIC CAPITAL, LP | 05/14/2025 | 28.37 K | $62.12 K | 100.00% | 0.03% |
| Y-INTERCEPT (HONG KONG) LTD | 05/06/2025 | 26.78 K | $58.64 K | 100.00% | 0.03% |
| CITIGROUP INC | 05/12/2025 | 25.77 K | $56.43 K | -66.58% | 0.03% |
| MORGAN STANLEY | 05/15/2025 | 21.65 K | $47.41 K | 196.68% | 0.02% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 16.88 K | $36.96 K | 100.00% | 0.02% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 14.98 K | $32.80 K | 100.00% | 0.02% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2025 | 14.80 K | $32.41 K | 0.00% | 0.02% |
| 05/14/2025 | 13.71 K | $30.03 K | 100.00% | 0.02% | |
| STIFEL FINANCIAL CORP | 05/14/2025 | 13.13 K | $28.75 K | 0.00% | 0.01% |
| 05/15/2025 | 13.01 K | $28.48 K | 100.00% | 0.01% | |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 11.10 K | $24.31 K | 100.00% | 0.01% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 05/15/2025 | 11.07 K | $24.24 K | 100.00% | 0.01% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 05/15/2025 | 10.38 K | $22.74 K | 100.00% | 0.01% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 9.04 K | $19.80 K | 100.00% | 0.01% |
| POINT72 (DIFC) LTD | 05/15/2025 | 1.98 K | $4.34 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 167 | $366 | 0.00% | 0.00% |
| ALPINE GLOBAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SYNERGY ASSET MANAGEMENT, LLC | 04/22/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibikase Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Inhibikase Therapeutics, Inc.. The most heavily invested institutionals were:
Sands Capital Ventures, LLC: 10.95 M
Soleus Capital Management, L.P.: 6.33 M
PERCEPTIVE ADVISORS LLC: 5.93 M
COMMODORE CAPITAL LP: 5.34 M
ADAR1 Capital Management, LLC: 5.12 M
VANGUARD GROUP INC: 2.85 M
50.62% of Inhibikase Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.27 M shares in the last 24 months. This purchase volume represents approximately $87.45 M in transactions.